# Luo Rushu

> Luo Rushu is a Series B investor at Huimei Capital backing Medical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Huimei Capital](https://shizune.co/investors/profile/huimei-capital)
- Total investments: 3
- Last investment: Jun 2024
- Lead investor: 33%
- Last updated: Aug 2026

Luo Rushu is a Series B investor at Huimei Capital focused on Medical and Health Care. Luo Rushu serves as a managing partner at Huimei Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series C | 1 | 33% |
| Series D | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Osteal Therapeutics | Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $50M | Series D | Jun 05, 2024 |  |
| Osteal Therapeutics | Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $23M | Series C | Sep 21, 2023 |  |
| Osteal Therapeutics | Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $30M | Series B | Dec 29, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Johnson & Johnson Development Corporation](https://shizune.co/investors/profile/johnson-johnson-development-corporation) — VC Fund, 3 deals together
- [Gideon Strategic Partners](https://shizune.co/investors/profile/gideon-strategic-partners) — VC Fund, 1 deal together
- [GOS Capital](https://shizune.co/investors/profile/gos-capital) — VC Fund, 1 deal together
- [HM Capital](https://shizune.co/investors/profile/hm-capital) — VC Fund, 1 deal together
- [Prism Venture Management](https://shizune.co/investors/profile/prism-venture-management) — VC Fund, 1 deal together
- [Medvest Capital](https://shizune.co/investors/profile/stanmore-medical-investments) — VC Fund, 1 deal together

## About Huimei Capital

VC Fund · Beijing, China

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

3 contacts available at Huimei Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Luo Rushu | Managing Partner & Co-founder | https://shizune.co/investors/profile/luo-rushu |
| Xu Wanning | Partner | https://shizune.co/investors/profile/xu-wanning |
| Song Longtao | Partner & Co-founder | https://shizune.co/investors/profile/song-longtao |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Luo Rushu invest in?

Luo Rushu invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Luo Rushu last invest?

The most recent investment recorded for Luo Rushu closed in Jun 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co